L-dopa 98%

L-L-DOPA is a natural form of DOPA used in the treatment of Parkinson’s disease. L-DOPA is the precursor of dopamine and product of tyrosine hydroxylase. Target: Dopamine Receptor L-DOPA (L-3,4-dihydroxyphenylalanine) is a chemical that is made and used as part of the normal biology of humans, some animals and plants. Some animals and humans make it via biosynthesis from the amino acid L-tyrosine. L-DOPA is the precursor to the neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine collectively known as catecholamines. L-DOPA can be manufactured and in its pure form is sold as apsychoactive drug with the INN levodopa; trade names include Sinemet, Parcopa, Atamet, Stalevo, Madopar, Prolopa, etc. As a drug it is used in the clinical treatment of Parkinson’s disease and dopamine-responsive dystonia. L-DOPA crosses the protective blood-brain barrier, whereas dopamine itself cannot. Thus, L-DOPA is used to increase dopamine concentrations in the treatment of Parkinson’s disease and dopamine-responsive dystonia. This treatment was made practical and proven clinically by George Cotzias and his coworkers, for which they won the 1969 Lasker Prize. In addition, L-DOPA, co-administered with a peripheral DDCI, has been investigated as a potential treatment for restless leg syndrome. However, studieshave demonstrated “no clear picture of reduced symptoms”. L-DOPA is the precursor to the neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline) collectively known as catecholamines.
Aside from its natural and essential biological role, L-DOPA is also used in the clinical treatment of Parkinson’s disease and dopamine-responsive dystonia. When used in a pharmaceutical context, the INN designation ‘levodopa’ is normally used.

Levodopa is a naturally occurring dietary supplement and psychoactive drug found in certain kinds of food and herbs (e.g., Mucuna pruriens, or velvet bean), and is synthesized from the amino acid L-tyrosine in the mammalian body and brain.

Levodopa  is the precursor to the neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline) collectively known as catecholamines.

Aside from its natural and essential biological role, L-DOPA is also used in the clinical treatment of Parkinson’s disease and dopamine-responsive dystonia. When used in a pharmaceutical context, the INN designation ‘levodopa’ is normally used.

Product Name:L-dopa 98%

Botanical Source:Mucuna Pruriens Extract

Part: Seed (Dried, 100% Natural)
Active Ingredient: Levodopa (L-dopa)
Extraction Method: Water/ Grain Alcohol
Form: off-white powder
Specification: 5%-99%
Test Method : HPLC
CAS Number: 59-92-7
Molecular formal: C9H11NO4
Molecular weight: 197.19
Solubility: Good solubility in hydro-alcoholic solution
GMO Status:GMO Free

Packing: in 25kgs fiber drums

Storage:Keep container unopened in cool, dry place,Keep away from strong light

Shelf Life:24 months from date of production

Function:

1. 1 .It is anti-paralysis agitans. Through the blood-brain barrier into the brain tissue, but by the decarboxylation of dopa decarboxylase into dopamine, play a role.
   2. For essential tremor and paralysis paralysis agitans syndrome of non-drug immunogenicity, and in better light, severe, or the elderly poor.
   3. Promote muscle growth,loss weight.
   4. Increased bone density and reversal of osteoporosis.
   5 .Dietary supplements.
   6. Treat parkinsonism and Pakinsonism syndrome, hepatic coma,hub functions to improve the patient awake, symptom improvement.
   7 .Promote sleep,improve immune system.
   8 .Weight loss.
   9 .Increase bone density and reversal of osteoporosis,increase muscle strength,enhance libido and sexual performance
   Application:

1.Mucuna Pruriens Extract can be used as dietary supplements.
2.Mucuna Pruriens Extract is used as a component in marine adhesives used by pelagic life.
3.Mucuna Pruriens Extract can promote muscle growt and increased bone density and reversal of osteoporosis.
4.Mucuna Pruriens Extract increase bone density and reversal of osteoporosis,increase muscle strength,enhance libido and sexual performance.
5.In clinical use, Mucuna Pruriens Extract is administered in the management of Parkinson’s disease and dopa-responsive dystonia.
6.For essential tremor and paralysis paralysis agitans syndrome of non-drug immunogenicity, and in better light, severe, or the elderly poor.
7.Treat parkinsonism and Pakinsonism syndrome, hepatic coma,hub functions to improve the patient awake, symptom improvement.
8.Mucuna Pruriens Extract is anti-paralysis agitans. Through the blood-brain barrier into the brain tissue, but by the decarboxylation of l-dopa decarboxylase into dopamine, play a role.
9.Mucuna Pruriens Extract is used for essential tremor and paralysis paralysis agitans syndrome of non-drug immunogenicity, and in better light, severe, or the elderly poor.

Several raw material suppliers as supply assurance.Strong Cooperative Institutions to supportInstitute of botany/Institution of microbiology/Academy of Science and Technology/University